method for treating a cancer in an individual, drug, kit, method, use or kit, and, method, drug or kit

• 收藏
• 分享

专利权人:

MERCK SHARP AND DOHME CORP.;INCYTE CORPORATION

发明人:

DAVID KAUFMAN,LANCE LEOPOLD

申请号：

BR112016017700

公开号：

BR112016017700A2

申请日:

2015.02.03

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

The present disclosure describes combination therapies comprising a programmed death receptor 1 antagonist (pd-1) and a selective indoleamine 2,3-dioxigenase 1 inhibitor (oxide 1), and the use of combination therapies for the treatment of cancer. , and in particular to treat cancers expressing pd-11.a presente descrição descreve terapias de combinação que compreendem um antagonista de receptor 1 de morte programada (pd-1) e um inibidor seletivo de indoleamina 2,3-dioxigenase 1 (ido1), e o uso das terapias de combinação para o tratamento de cancêr, e em particular, para tratar cânceres que expressam pd-l1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/